logo
Select company
Select metric
$ -32.6MEarning Before Interest & Taxes (EBIT)
VS
Market
20
Sector
45
Industry
17
History
93
$ 2.82Close
$ 0.73 - $ 3.83 52-Week Range
Ticker Information

Ticker

ESPR

Company Name

ESPERION THERAPEUTICS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

ESPERION THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ESPR - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -32.6M
3/31/2025$ -88.56M
12/31/2024$ 7.51M
9/30/2024$ -28.89M
6/30/2024$ -40.7M
3/31/2024$ -27.89M
12/31/2023$ -150.27M
9/30/2023$ -150.14M
6/30/2023$ -164.85M
3/31/2023$ -181.51M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ESPERION THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -83.16M.
  • Over the past 5 years, ESPERION THERAPEUTICS INC's average EBIT has been $ -136.07M.
  • The median EBIT for ESPERION THERAPEUTICS INC during this period was $ -150.21M
  • ESPERION THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ 7.51M.
  • The lowest EBIT recorded by ESPERION THERAPEUTICS INC in the same timeframe $ -291.39M

ESPERION THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
ACB : AURORA CANNABIS INC $ -16.41MCGC : CANOPY GROWTH CORP $ -373.19MEOLS : EVOLUS INC $ -40.34MSIGA : SIGA TECHNOLOGIES INC $ 107.16MRIGL : RIGEL PHARMACEUTICALS INC $ 106.88MLFCR : LIFECORE BIOMEDICAL INC $ -16.84MIRWD : IRONWOOD PHARMACEUTICALS INC $ 77.67METON : ETON PHARMACEUTICALS INC $ -807KOGI : ORGANIGRAM GLOBAL INC $ -1.47MAQST : AQUESTIVE THERAPEUTICS INC $ -48.08M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

ESPR - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -291.39M

Minimum

Jun 30, 2021

$ 7.51M

Maximum

Dec 31, 2024

$ -136.07M

Average

$ -150.21M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.48M with a standard deviation of $ 130.46M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.48M
median$ 847.86K
std$ 130.46M